HOME > > Products > PRONULIFE® (Probiotic) > PRONULIFE® OraProtect & OraProtect-L
PRONULIFE® OraProtect & OraProtect-L

Irreversible Oral Problems — Why Oral Probiotics Are Needed
According to research from the World Health Organization (WHO):- Nearly half of the global population (approx.3.5 billion people / 45%) suffer from oral and dental diseases
- The most common conditions includedental caries (tooth decay), periodontal disease, tooth loss, and oral cancer
- Untreated dental cariesis the most prevalent disease worldwide, affecting over2.5 billion people
- Approximately19% of adultsworldwide suffer from severe periodontal disease, with over1 billion cases
Incorporating probiotics into daily oral care is a proactive way to support oral health,
helping to maintain a healthy smile while boosting inner confidence.

Common Oral Pathogens
- Caries pathogen:
- Streptococcus mutans
Adheres to teeth, forms biofilm, metabolizes sugars, and causes cavities.
- Streptococcus mutans
- Periodontal pathogens:
- Porphyromonas gingivalis
- Fusobacterium nucleatum
- Aggregatibacter actinomycetemcomitans
Release toxins that trigger immune responses and cytokine release,
leading to alveolar bone and periodontal tissue destruction.
Creating an “Invisible Mask” for Oral Defense — Probiotic Solutions
The Glac R&D Center has screened premium oral probiotic strains from its extensive strain library, and clinical studies demonstrate multiple health benefits:- Inhibits the growth of common oral pathogens
- Reduces cariogenic bacteria while increasing beneficial oral probiotics
- Enhances Immunoglobulin A (IgA) production
- Improves oral microbiota environment (validated through NGS analysis)
- Supports oral immune functions and daily protection
Functional Probiotic Blends
Formula | Strain Composition |
PRONULIFE® OraProtect | L. salivarius AP-32 B. animalis subsp. lactis CP-9 L. paracasei ET-66 |
PRONULIFE® OraProtect-L | L. paracasei ET-66 L. salivarius AP-32 L. plantarum LPL-28 |
Patent Support
- TW I639389: Food, oral care, and pharmaceutical compositions containing Lactobacillus strains for inhibiting oral pathogens
- CN ZL2017111555468.8: Food, oral care, and pharmaceutical compositions containing Lactobacillus strains for inhibiting oral pathogens
Combining Glac’s patented technologies with clinical validation,
it delivers safe, science-based,
and competitive solutions for brand owners and ODM/OEM partners.
📧 Contact us: glac@glac.com.tw
References
- Heat-killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization.J Food Sci. 2011;76(5):260-267.
- The potential for probiotics to modulate inflammation of oral and throat by in vitro and animal model. The 6th Asian Conference on Lactic Acid Bacteria. 2011. P-AM11-78. P68.
- Potential of probiotic strains to modulate the inflammatory responses of epithelial and immune cells in vitro. New Microbiologica. 2013;36:167-179.
- Lactobacillus candidate strains have advantages on oral sterilization and might have whitening effectiveness. AFSLAB International Symposium. 2016.
- Functional characterization and application of probiotic strains for oral health care. CIFST Annual Meeting. 2018.
- Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens. Lett Appl Microbiol. 2020.
- Lozenges with probiotic strains enhance oral immune response and health. Oral Diseases. 2021.
- Viable and heat-killed probiotic strains improve oral immunity by elevating IgA concentration in the oral mucosa. Current Microbiology. 2021:1–9.